checkAd

     105  0 Kommentare Oncolytics Biotech Announces Full Exercise of Over-Allotment Option from Public Offering - Seite 3

    Company Contact
    Jon Patton
    Director of IR & Communication
    +1-858-886-7813
    jpatton@oncolytics.ca 

    Investor Relations for Oncolytics
    Timothy McCarthy
    LifeSci Advisors
    +1-917-679-9282
    tim@lifesciadvisors.com 

    Logo - https://mma.prnewswire.com/media/1762876/3912638/Oncolytics_Biotech_New_Logo.jpg

    Lesen Sie auch

    Cision View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-biotech-announces-full-exercise-of-over-allotment-option-from-public-offering-301920778.html


    The Oncolytics Biotech Stock at the time of publication of the news with a raise of +1,88 % to 3,26CAD on Toronto stock exchange (06. September 2023, 23:00 Uhr).
    Seite 3 von 3



    PR Newswire (engl.)
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von PR Newswire (engl.)
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Oncolytics Biotech Announces Full Exercise of Over-Allotment Option from Public Offering - Seite 3 CALGARY, AB, Sept. 7, 2023 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (NASDAQ: ONCY) (TSX: ONC) today announced that in connection with the previously announced underwritten public offering of US$15,000,750 (the …